PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor ActivityJing Yuan, Shubha Bagrodia|Molecular Cancer Therapeutics|2011Cited by 160
Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug designHengmiao Cheng, Eric Zhang, Matthew A. Marx et al.|MedChemComm|2010Cited by 73
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)Hengmiao Cheng, John C. Kath, Suvi T. M. Orr et al.|Journal of Medicinal Chemistry|2020Cited by 40
Abstract 5779: The discovery of the potent and selective PI3K/mTOR dual inhibitor PF-04691502 through structure-based drug designHenry S. Cheng, Peter C. Zhu, Shubha Bagrodia et al.|Cancer Research|2010Cited by 0